Introduction: The Future of Haemophilia A Treatment
When it comes to rare blood diseases, the introduction of Emicizumab, a bispecific monoclonal antibody, has been a significant milestone in the
When you collaborate with VSH Foundation, it's like unlocking a new dimension in healthcare
innovation.
Our research synergizes with your vision, combining expertise in health economics, policy analysis, advanced
analytics, and AI applications in healthcare. You’ll witness the fusion of cutting-edge methodologies and real-
world impact, as we work together to transform healthcare systems and improve patient outcomes globally.